Comments on: Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting

Comments on: Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting https://enterabio.com/news/entera-presents-markedly-enhanced-anabolic-effects-of-eb613-first-in-class-oral-pth1-34-tablet-in-postmenopausal-women-with-osteoporosis-at-high-risk-of-fracture-and-showcases-phase-3-design-at-as/ Global Leader in Oral Delivery of Therapeutic Proteins Tue, 13 Oct 2026 20:07:55 +0000 hourly 1 https://wordpress.org/?v=7.0.2